Patents by Inventor Greg Finak

Greg Finak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MARKERS, METHODS AND SYSTEMS FOR IDENTIFYING CELL POPULATIONS, DIAGNOSING, MONITORING, PREDICTING AND TREATING CONDITIONS
    Publication number: 20240094209
    Abstract: Disclosed herein are to markers, methods and systems for identifying cell populations, diagnosing, monitoring and treating cancer, including biomarkers predictive of response to immunotherapy treatment in Merkel cell carcinoma.
    Type: Application
    Filed: November 15, 2023
    Publication date: March 21, 2024
    Inventors: Evan Greene, Greg Finak, Raphael Gottardo
  • Markers, methods and systems for identifying cell populations, diagnosing, monitoring, predicting and treating conditions
    Patent number: 11860164
    Abstract: Disclosed herein are to markers, methods and systems for identifying cell populations, diagnosing, monitoring and treating cancer, including biomarkers predictive of response to immunotherapy treatment in Merkel cell carcinoma.
    Type: Grant
    Filed: June 11, 2020
    Date of Patent: January 2, 2024
    Assignee: Fred Hutchinson Cancer Center
    Inventors: Evan Greene, Greg Finak, Raphael Gottardo
  • MARKERS, METHODS AND SYSTEMS FOR IDENTIFYING CELL POPULATIONS, DIAGNOSING, MONITORING, PREDICTING AND TREATING CONDITIONS
    Publication number: 20200393465
    Abstract: Disclosed herein are to markers, methods and systems for identifying cell populations, diagnosing, monitoring and treating cancer, including biomarkers predictive of response to immunotherapy treatment in Merkel cell carcinoma.
    Type: Application
    Filed: June 11, 2020
    Publication date: December 17, 2020
    Applicant: FRED HUTCHINSON CANCER RESEARCH CENTER
    Inventors: Evan Greene, Greg Finak, Raphael Gottardo
  • Stroma Derived Predictor of Breast Cancer
    Publication number: 20100105564
    Abstract: The invention provides methods and compositions for use in the diagnosis and management of cancer, particularly breast cancer. The invention utilizes differential gene expression profiles in tumor associated stroma and normal stroma to compile a stroma derived prognostic predictor that classifies breast cancer patients according to clinical outcome. The application provides nucleic acids, antibodies, microarray chips and kits for use with the methods described in the application.
    Type: Application
    Filed: September 17, 2007
    Publication date: April 29, 2010
    Applicant: MCGILL UNIVERSITY
    Inventors: Morag Park, Michael Hallett, Greg Finak, Svetlana Sadekova